Proud to see our article “Respiratory Viruses in Patients with Haematological Malignancy (EPICOVIDEHA-EPIFLUEHA)” surpass 4,000 views. Grateful to all collaborators-turning knowledge into impact. 🔗 onlinelibrary.wiley.com/doi/full/10.... #ViewsMilestone #Hematology @salmantongarcia.bsky.social

📢🇩🇪 E-PEC multicentre study sheds light on MSI/MMR testing in endometrial cancer — real-world patterns for better patient stratification! 🔬🧬 👇https://www.mdpi.com/2075-4418/16/1/100

Had an amazing time at the #AEM XII Mycological Forum in #València! Great science, inspiring discussions, and fantastic energy from early-career researchers. Huge thanks to the organizers for the kind invitation — truly a great forum to be part of 🍄✨

🧫 Clinical insights into #mucormycosis in immunosuppressed patients: A multicentre study from Northern Argentina shows that timely care and targeted antifungals-especially liposomal amphotericin B-significantly improve survival. #FungalInfections #InfectiousDiseases @salmantongarcia.bsky.social

New nationwide ESCMID-EFISG study on fungal infection care in Colombia: major gaps in diagnostics, limited access to advanced tools & antifungals, with strong urban–rural disparities. www.sciencedirect.com/science/arti... @salmantongarcia.bsky.social @escmid.bsky.social @efisg-escmid.bsky.social

#EFISG webinars and more... www.clinicalsurveys.net/uc/EFISG_web... 2025 18/11, +@ESGAP_ABS Antifungal stewardship 11–12/12, XII Mycological Forum🇪🇸 16/12, Dermatophytes dx and tx 17/12, Dengue in hem/onc 22/12, IDWeek and CHEST hightlights 2026 20/01, Taxonomy 17/01, Point-of-care dx

Today in Rome 🇮🇹, at #LaboratorioSEIFEM, we discussed #hMPV and #RSV in hematology patients Still looking for cases of viral respiratory infections 🦠 of any kind within #EPICOVIDEHA / #EPIRESEHA 🧬 Always a pleasure to exchange ideas with our Italian colleagues! 🇮🇹

#Porto was alive with science! 🧫✨ From parasites to fungi, or endemic viruses... — great talks, great people, great vibes. Grateful to the organizing team for the kind invite!

🇨🇴 New @efisg-escmid.bsky.social study... Diagnostic and therapeutic capacity for fungal infections in #Colombia Findings show critical inequities in access to mycology labs, antifungal drugs, and @who.int-recommended diagnostics. Full study 👉 www.sciencedirect.com/science/arti...

🧬 COVID showed us the importance of viral vigilance—but respiratory infections go far beyond it. Catch the latest EPICOVIDEHA-EPIRESEHA webinar on influenza, RSV, hMPV and more: youtu.be/C2LTcEDnAoI?...

🚨 Final #DGHO2025 @dgho_ev day! Mon, Oct 27 (from 15:45, poster area) 🧬P1301 – Respiratory viruses in hem/onc 🦠P1303 – hMPV vs Influenza vs SARS-CoV-2 🧫P1304 – RSV vs Influenza vs SARS-CoV-2 🇵🇪P1305 – IFI dx and tx capacity - Peru 🇭🇳P1306– IFI dx and tx capacity - Honduras

Double dose of infection science today at #DGHO2025! 🧪 🕚 11:00 (S/T rooms) – Ceftazidim-avibactam in action 🕕 18:55 (Poster area) – Antifungal stewardship spotlight @dgho_ev

🌎 From Argentina to Germany! 🇦🇷➡️🇩🇪 4 posters sharing real-world infectious disease insights at @dgho_eV #DGHO2025 🗓️ Sat, 25 Oct | 17:45 | Postehalle 🦟 P416 #Dengue in hem/onc 🍄 P417 #Mucorales experience 💊 P418 #ISAV introduction 🧫 P419 #Aspergillus experience

🧫 Persistent candidemia: lessons from a European cohort In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%). Low EQUAL #Candida Scores predicted persistence 💡 Adherence saves lives 🔗 www.journalofinfection.com/article/S016...

“Beyond the Guidelines: Managing invasive fungal infections in critical illness” 🧫 Revisit to the 2024 ATS recommendations on: 1️⃣ Combination therapy for IPA 2️⃣ Empirical/prophylactic treatment for IC in ICU 👉 www.sciencedirect.com/science/arti...

Last Friday (Oct 15), @salmantongarcia.bsky.social spoke in Porto at the 1st Course on Invasive Fungal Infections, endorsed by the @EFISG-ESCMID Fungal Infection Study Group, sharing insights on the epidemiology and clinical challenges in HIV and other immunocompromised individuals. #IFIs #EFISG

We have some exciting news to share! Out #YISHAMERS @salmantongarcia.bsky.social, wants to extend an invitation for all of us to join the webinars courtesy of @efisg-escmid.bsky.social We are so glad to share this information and the QR codes for you to join to each of the following meetings

Work, science, and great vibes in Porto. Always a pleasure to come back :)

SAVE THE DATE 📅 Oct 22, 2025 | 16:00 CET | #EPIRESEHA: Insights and perspectives on viral #respiratory_infections F. Marchesi, IT – #Influenza J. Salmanton-García, DE – #RSV M. Biernat, PL – #hMPV B. Weinbergerova, CZ – #Other_viruses uni-koeln.zoom.us/meeting/register/r0LvqJ95QNWZuYhJXbUAIg

@efisg-escmid.bsky.social news... #Fluco-R #Candida_parapsilosis is a growing threat in hospitals. In a #multicenter matched cohort study, #echinocandins and #LAmB showed comparable outcomes for bloodstream infections journals.asm.org/doi/epub/10.... @escmid.bsky.social @taescmid.bsky.social

Today & tomorrow in Madrid: the Invasive Fungal Infections Course 🦠 (Oct 1–2, 16:00–19:30 CET) at Hospital Gregorio Marañón. Free & online! 🔗 docs.google.com/forms/d/e/1F... | In Spanish | with EFISG | @salmantongarcia.bsky.social on site 📸

📢 Join us on 22 Oct 2025, 16:00–18:00 CEST for the #EPIRESEHA Webinar: Insights on Viral Respiratory Infections! 🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts @olivercornely.bsky.social @salmantongarcia.bsky.social Register 👉 uni-koeln.zoom.us/meeting/regi...

🚨 Call for Papers 🚨 🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections! 📅 Deadline: 26 June 2026 🌍 Topics: Fungal pathogenesis Immune responses Antifungals Precision medicine & more... 👉 Submit here: www.biomedcentral.com/collections/...

Knowledge and capacity is not enough — it must be shared. Over half the world is still waiting… and people are dying. Let’s act now.

Day starts early... #TheHague #DenHaag

📊 #Rezafungin in real life 🌍🇪🇺🇺🇸 💉 Weekly echinocandin in invasive candidiasis/candidemia 🏥 15 pts | 4 countries ✅ Feasible for outpatients 💪 Active vs resistant #Candida 🛑 Access + admin barriers 👉 Real-world insights! onlinelibrary.wiley.com/doi/epdf/10....

🦠 Calling all #hematology researchers! Submit your work to #Infections in #Hematology: Advances in #Diagnosis #Management #Prevention #Patient_care 🗓️ Manuscript summary: 15 Dec 2025 🗓️ Full submission: 4 Apr 2026 🔗 frontiersin.org/research-top... @frontiersin.bsky.social

📢 Presented at #MYK2025 by @salmantongarcia.bsky.social : Current trends on antifungal prophylaxis in solid organ transplantation – an ESCMID/SEIMC study exploring real-world practices to guide IFI management in transplant centers. #Transplant #Antifungals

@institutpasteur.bsky.social Côte d'Ivoire 🇨🇮 tested RPA for rapid fungal diagnosis vs. traditional culture. ✅ 100% sensitivity + specificity for vaginal swabs ✅ Faster + field-friendly (days → minutes) ✅ Promising tool for low-resource settings www.sciencedirect.com/science/arti...

🚨 #SOT from #HIV+ #donors to HIV+ #recipients in #Europe. Spanish perspective ✅ High acceptance among #ESP transplant teams ✅ 127 HIV+ organs discarded in '98–'19 could be used ✅ #ESP legalized HIV+ donation in '25 www.clinicalmicrobiologyandinfection.org/article/S119... @seimc.bsky.social

🗓️ TOMORROW | 15:00 CET - Deadly fungal infections in HIV 🔗 us06web.zoom.us/webinar/regi... O. Lortholary,FR – Cryptococcus, Pneumocystis and Talaromyces A. Estévez,ES – Rare fungal infections in HIV C. Oprea,RO – Clinical cases @escmid.bsky.social @taescmid.bsky.social

🦠 New @efisg-escmid.bsky.social study on persistent candidemia (n=1188) 🇮🇹🇪🇸 ▫️ 25% persisted despite therapy ▫️ Linked to C. parapsilosis & C. auris ▫️ Source control protective ▫️ Persistence ↑ 30d mortality 🔗 www.journalofinfection.com/article/S016...

📢🦠Jornadas de Actualización en Micología Clínica “Dra. Hilda Romero” 📅Sáb 30 AGO 2025 | 8:00-14:00 📍Auditorio Megalabs, Caracas y💻Virtual 🎙Expertos de 🇻🇪🇨🇴🇧🇷🇵🇾🇲🇽 💲Prof. $20 | Est. $10 | Online $20 🔗Registro: forms.gle/xAUJcaWw72y4... ✉ [email protected] | @avmycolve

📌 New Review: Galactomannan in BAL fluid (≥1.01 ODI) is a reliable predictor for COVID-19-associated pulmonary aspergillosis (CAPA), while serum GM lacks diagnostic value. 🧪 Read more: doi.org/10.30699/ijp... #CAPA #COVID19 #GMTest @salmantongarcia.bsky.social

🚨 Invasive fungal infections remain a major challenge in hematologic cancer care. Help shape future research by sharing your experience in our short survey (10–15 min): 👉 www.clinicalsurveys.net/uc/AFproph_HemMal #Hematology #InfectiousDiseases #MedicalResearch

“Country-tiered APC pricing” at its finest... 🇬🇾 Guyana = 🇱🇺 Luxembourg 🇪🇨 Ecuador = 🇧🇳 Brunei 🇨🇮 Côte d'Ivoire = 🇧🇭 Bahrain Fair? Not really These bargains are a joke — and #OpenAccess is still a luxury for MANY #APCmadness #OpenAccess

🩸 Hematology #trainees — your voice matters! 💥 Improve ID training by sharing your experience in... 🔹 Infection care 🔹 Education 🔹 Confidence handling infections 🔹 Training satisfaction + needs 📋 10-min survey → www.clinicalsurveys.net/uc/ID_in_Hem...

Tips from a local for #TIMM2025 in #Bilbao Hotels within the transport area #1 Check flight companies flying to #Bilbao: en.wikipedia.org/wiki/Bilbao_...

🎉 Congratulations to @salmantongarcia.bsky.social ! His paper was named one of the Top 10 Cited Articles in IJAA over the past 2 years – a testament to its impact! Read it here: pubmed.ncbi.nlm.nih.gov/36640851/ #Mycology #Antimicrobials #TopCited #IJAA

🧪New @efisg-escmid.bsky.social study! How 🇧🇪🇳🇱🇱🇺 diagnose and treat invasive #fungal infections 🔬 PCR, GM, MALDI-TOF MS, triazoles and more—big 🇧🇪 vs 🇳🇱 differences in diagnostics & access 📊 Must-read! 🧵 🔗 onlinelibrary.wiley.com/doi/10.1111/... @escmid.bsky.social @olivercornely.bsky.social

🦠 New study reveals critical gaps in #fungal diagnostics & antifungal access across Peru. Urgent need for improved IFI care & equitable resource distribution. 📉⚕️ Read more 👉 doi.org/10.1128/spec... #GlobalHealth #Mycology #Peru #InfectiousDiseases @salmantongarcia.bsky.social

🔬 New study! What factors influence survival after a second allogeneic stem cell transplant? A 15-year analysis offers insights to guide patient selection & improve outcomes. Read more: doi.org/10.1007/s002... #Hematology #StemCellTransplant #AlloSCT @salmantongarcia.bsky.social

🚨 #Antifungal #prophylaxis in #SOT patients is evolving—but not uniformly. A new survey by @efisg-escmid.bsky.social @ESGICH @SITA @seimc.bsky.social @gesitraic-seimc.bsky.social sheds light on how prophylaxis is actually being used in transplant centers. 👇👇 link.springer.com/article/10.1...

🚨2nd alloSCT: A lifeline—with risk 🧬5-yr survival: 36% | 5-yr progress-free: 30% 💀1-yr non-relapsed survival: 60% ⚠️Poorer outcomes with relapse, high comorbidity-CI ≥3, <12mo gap between HSCT 💡DLI/maintenance may help 🎯Careful selection matters 🔗 link.springer.com/article/10.1...

🦠 Fungi Under Fire in Peru 🇵🇪 🧪 Microscopy? Widespread. 💊 Antifungals? Some gaps. 🧬 Advanced tools? Still growing. 💡 A call for smarter investment in fungal care → journals.asm.org/doi/10.1128/... @jmaquera2 @olivercornely.bsky.social

Raise ravens and they'll peck your eyes out. One of our students—who hasn’t even finished their degree yet—is already correcting double spaces! 🫣✍️ Good job Lukas!

🌍 Want to grow your global research network? Dr. Jon Salmanton-García shares practical tips on building meaningful international connections in science. Watch now! 👇 🎥 youtu.be/WyCKa3SM8WM #Networking #ScienceCommunity #GlobalResearch

🧪 Curious about how new antifungal treatments are developed? Dr. Jon Salmanton-García explains the full journey - from preclinical research to phase III trials, highlighting key challenges, innovations, and the fight against resistance. youtu.be/ekLy55XheKE #Antifungals #ClinicalTrials

🦠 How do ID training programs across Europe measure up in 2024? Jon Salmanton-García breaks down new survey findings in this YouTube talk: youtu.be/l3UV7l5zglQ Based on recent data and compared to 2018 & 2021 results. #InfectiousDiseases #IDtraining